10th October
Current Perspectives in Haematological Malignancies

The Lighthouse – Glasgow City Council, 11 Mitchell Lane, GLASGOW, G1 3NU

Chairs: Dr Anne Parker (Glasgow) and Professor Graham Jackson (Newcastle)

The challenges of CML resistance
CLL – heading for a cure?
Continuous therapy in myeloma – the future
Workshop : AML

ECHELON 1 : Brentuximab should be used first line in advanced Hodgkin lymphoma
GALLIUM : Obinutuzumab, not rituximab, should be used first line for patients with symptomatic follicular lymphoma

Confirmed Speakers:

  • Professor Mhairi Copland (Queen Eizabeth Hospital, Glasgow)
  • Dr George Follows (Addenbrooke’s Hospital, Cambridge)
  • Professor Tim Illidge (Christie Hospital, Manchester)
  • Professor Graham Jackson (NCCC, Newcastle)
  • Dr Andrew McMillan (Nottingham City Hospital)
  • Dr Wendy Osborne (Freeman Hospital, Newcastle)
  • Dr Steve Knapper (University Hospital, Wales)
  • Dr Mike Dennis (Christie Hospital, Manchester)
  • Dr Dominic Culligan (Aberdeen Royal Infirmary)

Registration Fees:

(inclusive of VAT @ 20%)


Trainees / Nurses*

Standard Fee (until 25th September)



Late Fee (from 26th September)




* 20 free places available for Trainees & Nurses (allocated on a first-come, first-served basis – please email alex@hartleytaylor.co.uk to check availability)


Registration questions: alex@hartleytaylor.co.uk
Sponsorship opportunities: julie@hartleytaylor.co.uk

Hartley Taylor Medical Communications Ltd
2, St George’s Court | St George’s Park
Kirkham | PR4 2EF